{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T22:20:56Z","timestamp":1776205256105,"version":"3.50.1"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T00:00:00Z","timestamp":1761696000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T00:00:00Z","timestamp":1761696000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82403218"],"award-info":[{"award-number":["82403218"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["8237112155"],"award-info":[{"award-number":["8237112155"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Surg Onc"],"DOI":"10.1186\/s12957-025-04066-9","type":"journal-article","created":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T13:52:29Z","timestamp":1761745949000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Postoperative prognostic factors in patients with T2 gallbladder cancer: a meta-analysis"],"prefix":"10.1186","volume":"23","author":[{"given":"Yue","family":"Zuo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sen","family":"Le","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Changqi","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhengdong","family":"Deng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Xia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianming","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,29]]},"reference":[{"key":"4066_CR1","doi-asserted-by":"publisher","DOI":"10.21037\/cco.2019.08.13","volume":"8","author":"MA Schmidt","year":"2019","unstructured":"Schmidt MA, Marcano-Bonilla L, Roberts LR. Gallbladder cancer: epidemiology and genetic risk associations. Chin Clin Oncol. 2019;8:31.","journal-title":"Chin Clin Oncol"},{"key":"4066_CR2","doi-asserted-by":"publisher","first-page":"93","DOI":"10.5114\/ceh.2019.85166","volume":"5","author":"P Rawla","year":"2019","unstructured":"Rawla P, Sunkara T, Thandra KC, Barsouk A. Epidemiology of gallbladder cancer. Clin Exp Hepatol. 2019;5:93\u2013102.","journal-title":"Clin Exp Hepatol"},{"key":"4066_CR3","doi-asserted-by":"publisher","first-page":"455","DOI":"10.4143\/crt.2019.271","volume":"52","author":"YN Sung","year":"2020","unstructured":"Sung YN, Song M, Lee JH, Song KB, Hwang DW, Ahn CS, et al. Validation of the 8th edition of the American Joint Committee on Cancer staging system for gallbladder cancer and implications for the follow-up of patients without node dissection. Cancer Res Treat. 2020;52:455\u201368.","journal-title":"Cancer Res Treat"},{"key":"4066_CR4","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1097\/SLA.0000000000000728","volume":"261","author":"J Shindoh","year":"2015","unstructured":"Shindoh J, de Aretxabala X, Aloia TA, Roa JC, Roa I, Zimmitti G, et al. Tumor location is a strong predictor of tumor progression and survival in T2 gallbladder cancer: an international multicenter study. Ann Surg. 2015;261:733\u20139.","journal-title":"Ann Surg"},{"key":"4066_CR5","doi-asserted-by":"publisher","first-page":"4342","DOI":"10.1097\/JS9.0000000000001403","volume":"110","author":"TR Lv","year":"2024","unstructured":"Lv TR, Wang JK, Li FY, Hu HJ. Prognostic factors for resected cases with gallbladder carcinoma: a systematic review and meta-analysis. Int J Surg. 2024;110:4342\u201355.","journal-title":"Int J Surg"},{"key":"4066_CR6","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.705299","volume":"11","author":"W Zhang","year":"2021","unstructured":"Zhang W, Huang Z, Wang WE, Che X. Survival benefits of simple versus extended cholecystectomy and lymphadenectomy for patients with T2 gallbladder cancer: a propensity-matched population-based study (2010 to 2015). Front Oncol. 2021;11:705299.","journal-title":"Front Oncol"},{"key":"4066_CR7","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1186\/s12885-020-07334-x","volume":"20","author":"A Sachan","year":"2020","unstructured":"Sachan A, Saluja SS, Nekarakanti PK, Nimisha, Mahajan B, Nag HH, Mishra PK. Raised CA19-9 and CEA have prognostic relevance in gallbladder carcinoma. BMC Cancer. 2020;20:826.","journal-title":"BMC Cancer"},{"key":"4066_CR8","doi-asserted-by":"publisher","first-page":"E16","DOI":"10.1503\/cjs.019719","volume":"65","author":"S Tharmalingam","year":"2022","unstructured":"Tharmalingam S, Flemming J, Richardson H, Hurlbut D, Cleary S, Nanji S. Surgical practice patterns and outcomes in T2 and T3 gallbladder cancer: a population-based study. Can J Surg. 2022;65:E16-24.","journal-title":"Can J Surg"},{"key":"4066_CR9","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1200\/JCO.18.02178","volume":"37","author":"RT Shroff","year":"2019","unstructured":"Shroff RT, Kennedy EB, Bachini M, Bekaii-Saab T, Crane C, Edeline J, et al. Adjuvant therapy for resected biliary tract cancer: ASCO clinical practice guideline. J Clin Oncol. 2019;37:1015\u201327.","journal-title":"J Clin Oncol"},{"key":"4066_CR10","doi-asserted-by":"publisher","DOI":"10.1186\/s13014-020-1459-x","volume":"15","author":"B Ren","year":"2020","unstructured":"Ren B, Guo Q, Yang Y, Liu L, Wei S, Chen W, et al. A meta-analysis of the efficacy of postoperative adjuvant radiotherapy versus no radiotherapy for extrahepatic cholangiocarcinoma and gallbladder carcinoma. Radiat Oncol. 2020;15:15.","journal-title":"Radiat Oncol"},{"key":"4066_CR11","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1000100","volume":"6","author":"A Liberati","year":"2009","unstructured":"Liberati A, Altman DG, Tetzlaff J, Mulrow C, G\u00f8tzsche PC, Ioannidis JP, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med. 2009;6:e1000100.","journal-title":"PLoS Med"},{"key":"4066_CR12","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/j.ejso.2022.10.020","volume":"49","author":"CH Kwon","year":"2023","unstructured":"Kwon CH, Seo HI, Kim DU, Han SY, Kim S, Lee SJ, et al. HER2 status based on breast cancer guidelines as a useful prognostic marker of T2 gallbladder cancer. Eur J Surg Oncol. 2023;49:392\u20138.","journal-title":"Eur J Surg Oncol"},{"key":"4066_CR13","doi-asserted-by":"publisher","first-page":"2779","DOI":"10.1245\/s10434-014-4300-7","volume":"22","author":"H Lee","year":"2015","unstructured":"Lee H, Choi DW, Park JY, Youn S, Kwon W, Heo JS, et al. Surgical strategy for T2 gallbladder cancer according to tumor location. Ann Surg Oncol. 2015;22:2779\u201386.","journal-title":"Ann Surg Oncol"},{"key":"4066_CR14","doi-asserted-by":"publisher","first-page":"1672","DOI":"10.1002\/jso.25085","volume":"117","author":"JF Wang","year":"2018","unstructured":"Wang JF, Liu JZ, Chang QM, Yang B, Li S, Gu C. The association between preoperative serum interleukin-6 levels and postoperative prognosis in patients with T2 gallbladder cancer. J Surg Oncol. 2018;117:1672\u20138.","journal-title":"J Surg Oncol"},{"key":"4066_CR15","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11092644","author":"JK Cho","year":"2022","unstructured":"Cho JK, Kim JR, Jang JY, Kim HG, Kim JM, Kwag SJ, et al. Comparison of the oncological outcomes of open versus laparoscopic surgery for T2 gallbladder cancer: a propensity-score-matched analysis. J Clin Med. 2022. https:\/\/doi.org\/10.3390\/jcm11092644.","journal-title":"J Clin Med"},{"key":"4066_CR16","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.jss.2019.02.043","volume":"240","author":"J Navarro","year":"2019","unstructured":"Navarro J, Kang I, Hwang HK, Yoon DS, Lee WJ, Kang CM. Glucose to lymphocyte ratio as a prognostic marker in patients with resected pT2 gallbladder cancer. J Surg Res. 2019;240:17\u201329.","journal-title":"J Surg Res"},{"key":"4066_CR17","doi-asserted-by":"publisher","DOI":"10.1007\/s00423-023-02823-6","author":"M Akabane","year":"2023","unstructured":"Akabane M, Shindoh J, Kohno K, Okubo S, Matsumura M, Takazawa Y, et al. Subserosal vascular density predicts oncological features of T2 gallbladder cancer. Langenbecks Arch Surg. 2023. https:\/\/doi.org\/10.1007\/s00423-023-02823-6.","journal-title":"Langenbecks Arch Surg"},{"key":"4066_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.suronc.2021.101693","author":"MK Sung","year":"2022","unstructured":"Sung MK, Lee W, Lee JH, Song KB, Kim SC, Kwak BJ, et al. Comparing survival rate and appropriate surgery methods according to tumor location in T2 gallbladder cancer. Surg Oncol. 2022. https:\/\/doi.org\/10.1016\/j.suronc.2021.101693.","journal-title":"Surg Oncol"},{"key":"4066_CR19","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1016\/j.surg.2020.12.039","volume":"169","author":"MY Chen","year":"2021","unstructured":"Chen MY, Cao JS, Xiang YK, Ma XC, Bai Y, Lai QH, Tong CH, Ma ZY, Topatana W, Hu JH, et al. Hepatectomy strategy for T2 gallbladder cancer between segment IVb and V resection and wedge resection: A propensity score-matched. Surgery. 2021;169:1304\u201311.","journal-title":"Surgery"},{"key":"4066_CR20","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.1007\/s11605-022-05368-z","volume":"26","author":"MY Oh","year":"2022","unstructured":"Oh MY, Kim H, Sohn HJ, Lee S, Lee M, Kim HS, et al. Long-term oncologic outcomes for T2 gallbladder cancer according to the type of surgery performed and the optimal timing for sequential extended cholecystectomy. J Gastrointest Surg. 2022;26:1705\u201312.","journal-title":"J Gastrointest Surg"},{"key":"4066_CR21","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/j.jamcollsurg.2008.02.031","volume":"207","author":"NG Coburn","year":"2008","unstructured":"Coburn NG, Cleary SP, Tan JC, Law CH. Surgery for gallbladder cancer: a population-based analysis. J Am Coll Surg. 2008;207:371\u201382.","journal-title":"J Am Coll Surg"},{"key":"4066_CR22","first-page":"934","volume":"23","author":"Q Li","year":"2024","unstructured":"Li Q, Tang Z, Liu H, Ma Y, Chen C, Zhang D, et al. Efficacy analysis of liver wedge resection and liver b and segmentectomy for T2 gallbladder carcinoma. Chin J Dig Surg. 2024;23:934\u201343.","journal-title":"Chin J Dig Surg"},{"key":"4066_CR23","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1007\/s11605-009-1132-z","volume":"14","author":"SB Choi","year":"2010","unstructured":"Choi SB, Han HJ, Kim CY, Kim WB, Song TJ, Suh SO, et al. Surgical outcomes and prognostic factors for T2 gallbladder cancer following surgical resection. J Gastrointest Surg. 2010;14:668\u201378.","journal-title":"J Gastrointest Surg"},{"key":"4066_CR24","doi-asserted-by":"publisher","DOI":"10.3346\/jkms.2018.33.e186","volume":"33","author":"SE Lee","year":"2018","unstructured":"Lee SE, Kim SW, Han HS, Lee WJ, Yoon DS, Cho BH, et al. Surgical strategy for T2 gallbladder cancer: nationwide multicenter survey in Korea. J Korean Med Sci. 2018;33:e186.","journal-title":"J Korean Med Sci"},{"key":"4066_CR25","doi-asserted-by":"publisher","first-page":"135","DOI":"10.4174\/astr.2018.94.3.135","volume":"94","author":"TJ Park","year":"2018","unstructured":"Park TJ, Ahn KS, Kim YH, Kim TS, Hong JH, Kang KJ. The optimal surgical resection approach for T2 gallbladder carcinoma: evaluating the role of surgical extent according to the tumor location. Ann Surg Treat Res. 2018;94:135\u201341.","journal-title":"Ann Surg Treat Res"},{"key":"4066_CR26","doi-asserted-by":"publisher","first-page":"140","DOI":"10.5009\/gnl15080","volume":"10","author":"W Jung","year":"2016","unstructured":"Jung W, Jang JY, Kang MJ, Chang YR, Shin YC, Chang J, et al. Effects of surgical methods and tumor location on survival and recurrence patterns after curative resection in patients with 12 gallbladder cancer. Gut Liver. 2016;10:140\u20136.","journal-title":"Gut Liver"},{"key":"4066_CR27","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1002\/bjs.11618","volume":"107","author":"W Kwon","year":"2020","unstructured":"Kwon W, Kim H, Han Y, Hwang YJ, Kim SG, Kwon HJ, et al. Role of tumour location and surgical extent on prognosis in T2 gallbladder cancer: an international multicentre study. Br J Surg. 2020;107:1334\u201343.","journal-title":"Br J Surg"},{"key":"4066_CR28","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/j.surg.2017.05.004","volume":"162","author":"W Lee","year":"2017","unstructured":"Lee W, Jeong CY, Jang JY, Kim YH, Roh YH, Kim KW, et al. Do hepatic-sided tumors require more extensive resection than peritoneal-sided tumors in patients with T2 gallbladder cancer? Results of a retrospective multicenter study. Surgery. 2017;162:515\u201324.","journal-title":"Surgery"},{"key":"4066_CR29","doi-asserted-by":"crossref","unstructured":"Zhang W, Huang ZK, Wang WE, Che X. Survival benefits of Simple\u2009<\u2009i\u2009>\u2009versus\u2009extended cholecystectomy and lymphadenectomy for patients with T2 gallbladder cancer: a propensity-matched population-based study (2010 to 2015). Front Oncol. 2021;11.","DOI":"10.3389\/fonc.2021.705299"},{"key":"4066_CR30","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1097\/SLA.0000000000005908","volume":"278","author":"Y Park","year":"2023","unstructured":"Park Y, Lee JS, Lee B, Jo Y, Lee E, Kang M, et al. Prognostic effect of liver resection in extended cholecystectomy for T2 gallbladder cancer revisited: a retrospective cohort study with propensity score-matched analysis. Ann Surg. 2023;278:985\u201393.","journal-title":"Ann Surg"},{"key":"4066_CR31","doi-asserted-by":"publisher","DOI":"10.1177\/1073274820915514","volume":"27","author":"WJ Kim","year":"2020","unstructured":"Kim WJ, Lim TW, Park PJ, Choi SB, Kim WB. Clinicopathological differences in T2 gallbladder cancer according to tumor location. Cancer Control. 2020;27:1073274820915514.","journal-title":"Cancer Control"},{"key":"4066_CR32","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.asjsur.2021.05.005","volume":"45","author":"P Burasakarn","year":"2022","unstructured":"Burasakarn P, Thienhiran A, Hongjinda S, Fuengfoo P. The optimal extent of surgery in T2 gallbladder cancer and the need for hepatectomy: a meta-analysis. Asian J Surg. 2022;45:33\u20138.","journal-title":"Asian J Surg"},{"key":"4066_CR33","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10153317","author":"H Kang","year":"2021","unstructured":"Kang H, Choi YS, Suh SW, Choi G, Do JH, Oh HC, et al. Prognostic significance of tumor location in T2 gallbladder cancer: a systematic review and meta-analysis. J Clin Med. 2021. https:\/\/doi.org\/10.3390\/jcm10153317.","journal-title":"J Clin Med"},{"key":"4066_CR34","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1007\/s13304-021-01150-z","volume":"73","author":"SM Khan","year":"2021","unstructured":"Khan SM, Emile SH, Choudhry MS, Sumbal R. Tumor location and concurrent liver resection, impact survival in T2 gallbladder cancer: a meta-analysis of the literature. Update Surg. 2021;73:1717\u201326.","journal-title":"Update Surg"},{"key":"4066_CR35","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1007\/s00423-020-01878-z","volume":"405","author":"B Widmann","year":"2020","unstructured":"Widmann B, Warschkow R, Beutner U, Weitzendorfer M, Ukegjini K, Schmied BM, et al. Effect of lymphadenectomy in curative gallbladder cancer treatment: a systematic review and meta-analysis. Langenbecks Arch Surg. 2020;405:573\u201384.","journal-title":"Langenbecks Arch Surg"},{"key":"4066_CR36","doi-asserted-by":"publisher","first-page":"13","DOI":"10.4251\/wjgo.v16.i1.13","volume":"16","author":"ET Pavlidis","year":"2024","unstructured":"Pavlidis ET, Galanis IN, Pavlidis TE. New trends in diagnosis and management of gallbladder carcinoma. World J Gastrointest Oncol. 2024;16:13\u201329.","journal-title":"World J Gastrointest Oncol"},{"key":"4066_CR37","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.3346\/jkms.2014.29.10.1333","volume":"29","author":"SE Lee","year":"2014","unstructured":"Lee SE, Kim KS, Kim WB, Kim IG, Nah YW, Ryu DH, et al. Practical guidelines for the surgical treatment of gallbladder cancer. J Korean Med Sci. 2014;29:1333\u201340.","journal-title":"J Korean Med Sci"},{"key":"4066_CR38","unstructured":"Network NCC. NCCN clinical practice guidelines in oncology: hepatobiliary cancers. Natl Compr Canc Netw. 2021."},{"key":"4066_CR39","unstructured":"Branch of Biliary Surgery CSSCCoBS. Guideline for the diagnosis and treatment of gallbladder carcinoma (2019 ed). 2020;58:234\u2013244."},{"key":"4066_CR40","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-020-07578-7","volume":"20","author":"W Jiang","year":"2020","unstructured":"Jiang W, Zhao B, Li Y, Qi D, Wang D. Modification of the 8th American joint committee on cancer staging system for gallbladder carcinoma to improve prognostic precision. BMC Cancer. 2020;20:1129.","journal-title":"BMC Cancer"},{"key":"4066_CR41","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.542005","volume":"10","author":"J Li","year":"2020","unstructured":"Li J, Sun Y, Zhao B, Tang C, Fan D, Jiang W, et al. Lymph node ratio-based staging system for gallbladder cancer with fewer than six lymph nodes examined. Front Oncol. 2020;10:542005.","journal-title":"Front Oncol"},{"issue":"10","key":"4066_CR42","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1007\/s00432-024-05975-0","volume":"150","author":"W Miao","year":"2024","unstructured":"Miao W, Liu F, Guo Y, Zhang R, Wang Y, Xu J. Research progress on prognostic factors of gallbladder carcinoma. J Cancer Res Clin Oncol. 2024;150:447.","journal-title":"J Cancer Res Clin Oncol"},{"key":"4066_CR43","first-page":"243","volume":"58","author":"Biliary Surgery Group of Surgery Branch CMA, Biliary Surgery Professional Committee of Surgeon Branch CMDA","year":"2020","unstructured":"Biliary Surgery Group of Surgery Branch CMA, Biliary Surgery Professional Committee of Surgeon Branch CMDA. Diagnosis and treatment guidelines for gallbladder carcinoma (2019 edition). Chin J Surg. 2020;58:243\u201351.","journal-title":"Chin J Surg"},{"key":"4066_CR44","first-page":"215","volume":"34","author":"YX Feng","year":"2025","unstructured":"Feng YX, Qiu P, Wang JM. Difficulties, controversies, and reflections in the surgical treatment of gallbladder carcinoma. Chin J Gen Surg. 2025;34:215\u201321.","journal-title":"Chin J Gen Surg"}],"container-title":["World Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-025-04066-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12957-025-04066-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-025-04066-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T01:03:32Z","timestamp":1761786212000},"score":1,"resource":{"primary":{"URL":"https:\/\/wjso.biomedcentral.com\/articles\/10.1186\/s12957-025-04066-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,29]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4066"],"URL":"https:\/\/doi.org\/10.1186\/s12957-025-04066-9","relation":{},"ISSN":["1477-7819"],"issn-type":[{"value":"1477-7819","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,29]]},"assertion":[{"value":"2 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"406"}}